I don't think PAR is looking for any CR anytime soon with cash of $83M in the bank (from last report) and this will probably last until end of this year. With June report from 008 study is only handful weeks and confirmation on dose will provide a milestone for 003 study, the potential of PAR recovery could be 50-100% in a day. You need to have a patience with ground-breaking breakthrough in medical science and need to understand the various process and efficacy of drug approving authority
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-250
-
- There are more pages in this discussion • 137 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.035(12.7%) |
Mkt cap ! $108.4M | |||
| Open | High | Low | Value | Volume |
| 27.5¢ | 31.0¢ | 27.5¢ | $108.9K | 371.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 17420 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PAR (ASX) Chart |